Attention Investors: Beware of fraudulent Calls, SMS or Emails assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Mobile Invest / TradeLite App only from Google Play Store or Apple App Store. Click Here to know more.
Experience finance made simple on the new ABCD app!
Scan to Download the App
One stop solution for all stock market enthusiasts
Whatsapp us!! We are Available.
Send HI on 8828800038
For Broking services
Call Toll Free Number :
1800-270-7000
( Mon - Fri: 9AM - 11PM )
( Sat & Sun: 9AM - 09PM )
Call N Trade
Call :
1800-108-9999 & Dial 1
( 9AM to 11:30PM )
Acquire & service self-trading online & offline clients. Archive large-scale business success with the entire product range offered by us.
Earn while you refer client. No need to set up your own infrastructure.
Join our referral program, earn rewards when friends and family open accounts & transact. Spread the word, multiply your earnings!
Join the Entrepreneurial Tribe!
Aditya Birla Money Limited
Symbol : FDC | BSE Code : 531599 | Sector : PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN
Market Cap (₹ Cr.)
Turnover (₹ Cr.)
28/04/2024 BSE -1.10(-0.24)Close Price: ₹ 455.80 Volume: 2,937.00
28/04/2024 BSE 4.15(0.92)Close Price: ₹ 456.90 Volume: 6,353.00
28/04/2024 BSE 8.00(1.80)Close Price: ₹ 452.75 Volume: 10,345.00
28/04/2024 BSE -5.40(-1.20)Close Price: ₹ 444.75 Volume: 3,199.00
28/04/2024 BSE 1.50(0.33)Close Price: ₹ 450.15 Volume: 3,122.00
No Data Available
FDC Limited has informed the Exchange about Loss of share certificates
FDC Ltd - FDC Limited - Other General Purpose
FDC Ltd - FDC Limited - Loss of Share Certificates
FDC Ltd - FDC Limited - Disclosure under SEBI Takeover Regulations
In Cr.
FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). FDC's formulation department designs and develops products for various global markets and the highly regulated markets of US and Europe. The company has built a visible presence in the Regulated and Emerging markets. Promoted as a partnership firm in 1936 by the late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods Fairdeal Corporation (P) Ltd, as the company was known, was converted into a private limited company in September 23rd, 1940. It set up a formulation unit at Jogeshwari, Bombay in 1949.FDC has 2 wholly owned subsidiaries namely FDC Inc., USA and FDC International Ltd, UK and 1 Joint Venture business, namely Fair Deal Corporation Pharmaceutical SA (Pty) Ltd. at South Africa as on 31 March 2019.FDC manufactures Electral, oral rehydration salt (ORS), being a leader in this segment. FDC manufactures bulk drugs, formulations and food products. The plant at Roha manufactures pharma dosage forms, food products and bulk drugs for the anti-rheumatic, anti-asthmatic, opthalmic and ENT segments. The company part financed its technical upgradation/modernisation/backward integration/expansion plans from the proceeds of its initial public issue in Jan.'96. The company set up a modern manufacturing plant at Goa for manufacture of tablet dosage forms. The plant has commenced commercial production in Sep 2000. The plant is designed to meet UK/US standards on solid dosage form.In Feb. 2001, the company has signed a marketing tie-updeal with Aspen Pharmacare of South Africa. Through this alliance, FDC will be initially marketing 10-12 ophthalmic products manufactured at its plants in India and approved by the UK Medicines Control Agency in South Africa.FDC will also enter into a licensing arrange